Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Frontiers in Cell and Developmental Biology|November 10, 2016
Single Cell Isolation and AnalysisPing Hu, Wenhua Zhang, Hongbo Xin, et al.Breast Cancer Research : BCR|August 9, 2008
Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patientsGlenn Deng, Michael Herrler, David Burgess, et al.Tissue Engineering. Part A|May 31, 2024
Oxidized Low-Density Lipoprotein Decreases the Survival of Bone Marrow Stem Cells via Inhibition of Bcl-2 ExpressionXin Li, Yu Li, Hao Yu, et al.BMC Cancer|June 9, 2026
Evidence for the prognostic value of TP53 mutations in circulating tumor DNA across solid malignancies: a systematic review and meta-analysisLan Jinyan, Liang Yibin, Qin Jiangkui, et al.American Journal of Physiology. Cell Physiology|December 23, 2004
Microarray-based comparison of three amplification methods for nanogram amounts of total RNARuchira Singh, Rajanikanth J Maganti, Sairam V Jabba, et al.Oncology Letters|January 19, 2019
miR-34a inhibits esophageal squamous cell carcinoma progression via regulation of FOXM1Haibo Zhou, Li Yang, Xinhua Xu, et al.BMC Cancer|June 21, 2014
Single cell mutational analysis of PIK3CA in circulating tumor cells and metastases in breast cancer reveals heterogeneity, discordance, and mutation persistence in cultured disseminated tumor cells from bone marrowGlenn Deng, Sujatha Krishnakumar, Ashley A Powell, et al.Biotechniques|November 25, 2004
Linear mRNA amplification from as little as 5 ng total RNA for global gene expression analysisAlan Dafforn, Pengchin Chen, Glenn Deng, et al.Journal of Cancer Research and Clinical Oncology|May 10, 2026
Enhanced detection of bladder cancer using combined circulating tumor cells, urine-derived epithelial cells, and molecular biomarkersZhijie Jiang, Cheng Yuan, Honggang Yuan, et al.Breast Cancer Research : BCR|April 9, 2014
Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibitionHaiyu Zhang, Adam L Cohen, Sujatha Krishnakumar, et al.Pageof 2